Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies-Reference-Cited by-同舟云学术

Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies

Published:2017-12 Issue:12 Volume:17 Page:e79-e85
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Nishiwaki Satoshi^ORCID,Okuno Shingo,Suzuki Kotaro,Kurahashi Shingo,Sugiura Isamu

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference28 articles.

1. Clinical analysis of 152 cases of multiple primary malignant tumors in 15,398 patients with malignant tumors;Liu;PLoS One,2015

2. Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery;Yoshida;Int J Clin Oncol,2016

3. Synchronous diagnosis of multiple myeloma, breast cancer, and monoclonal B-cell lymphocytosis on initial presentation;Vennepureddy;Case Rep Oncol Med,2016

4. Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma;Kader;J Laryngol Otol,2016

5. Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: a case report;Zuo;Medicine (Baltimore),2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Single-center Experience of Synchronous and Metachronous Hematologic and Oncologic Tumors;OSMANGAZİ JOURNAL OF MEDICINE;2023-09-04

2. Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study;BMC Cancer;2022-06-11

3. Evaluation of the Patients with Hematological Malignancies along with Synchronous or Metachronous Solid Tumors;UHOD-ULUSLAR HEMATOL;2021

4. Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients;Tumori Journal;2019-04-04